Ibrutinib inhibition of Bruton protein-tyrosine kinase (BTK) in the treatment of B cell neoplasms

Title
Ibrutinib inhibition of Bruton protein-tyrosine kinase (BTK) in the treatment of B cell neoplasms
Authors
Keywords
Catalytic spine, Chronic lymphocytic leukemia, K/E/D/D, Mantle cell lymphoma, Waldenström macroglobulinemia
Journal
PHARMACOLOGICAL RESEARCH
Volume 113, Issue -, Pages 395-408
Publisher
Elsevier BV
Online
2016-09-17
DOI
10.1016/j.phrs.2016.09.011

Ask authors/readers for more resources

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started